Concordia International Rx UK Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Concordia International Rx UK Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11259
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥100,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Concordia International Rx UK Ltd (Concordia) formerly Amdipharm Mercury Company Ltd, a subsidiary of Concordia International Corp, is a manufacturer of pharmaceutical products and orphan drugs. The company’s products include acetazolamide, adenosine, adrenaline acid tartrate, alfacalcidol, aminophylline, ampres, anturn, apresoline, argipressin, atropine sulfate, baratol, bipuvacaine and carbimazole, among others. It offers its products in various formulations such as tablets, injectables, eye drops and ointment. Concordia International markets its products through a network of distributors. The company operates through its offices in India, Ireland, the UK, Sweden, Dubai and Australia. Concordia is headquartered in London, the UK.

Concordia International Rx UK Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Concordia International Rx UK Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Concordia International Rx UK Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Concordia International Rx UK Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Concordia International Rx UK Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Concordia International Rx UK Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Concordia International Rx UK Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Concordia International Rx UK Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Amdipharm Mercury Completes Acquisition Of Fucithalmic, Ophthalmic Medicine, From LEO Pharma 11
Private Equity 12
Cinven Acquires Mercury Pharma from HgCapital for USD730 Million 12
Merger 14
Mercury Pharma and Amdipharm Merge 14
Acquisition 15
Concordia Healthcare Acquires Amdipharm Mercury for USD3.54 Billion 15
Amdipharm Mercury Acquires Boucher and Muir 17
Amdipharm Mercury acquires Primegen 18
Mercury Pharma Acquires Focus Pharma 19
Amdipharm Mercury Acquires Abcur, Specialty Pharma Company 20
Concordia International Rx UK Ltd – Key Competitors 21
Concordia International Rx UK Ltd – Key Employees 22
Concordia International Rx UK Ltd – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
Concordia International Rx UK Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Concordia International Rx UK Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Concordia International Rx UK Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Concordia International Rx UK Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Concordia International Rx UK Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Concordia International Rx UK Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Concordia International Rx UK Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Amdipharm Mercury Completes Acquisition Of Fucithalmic, Ophthalmic Medicine, From LEO Pharma 11
Cinven Acquires Mercury Pharma from HgCapital for USD730 Million 12
Mercury Pharma and Amdipharm Merge 14
Concordia Healthcare Acquires Amdipharm Mercury for USD3.54 Billion 15
Amdipharm Mercury Acquires Boucher and Muir 17
Amdipharm Mercury acquires Primegen 18
Mercury Pharma Acquires Focus Pharma 19
Amdipharm Mercury Acquires Abcur, Specialty Pharma Company 20
Concordia International Rx UK Ltd, Key Competitors 21
Concordia International Rx UK Ltd, Key Employees 22
Concordia International Rx UK Ltd, Other Locations 23
Concordia International Rx UK Ltd, Subsidiaries 23

List of Figures
Concordia International Rx UK Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Concordia International Rx UK Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Concordia International Rx UK Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Concordia International Rx UK Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Concordia International Rx UK Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Concordia International Rx UK Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Concordia International Rx UK Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Concordia International Rx UK Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Concordia International Rx UK Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Concordia International Rx UK Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Radico Khaitan Ltd.:企業の戦略・SWOT・財務情報
    Radico Khaitan Ltd. - Strategy, SWOT and Corporate Finance Report Summary Radico Khaitan Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • IBIDEN Co Ltd (4062):企業の財務・戦略的SWOT分析
    IBIDEN Co Ltd (4062) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • First Abu Dhabi Bank PJSC (FAB):企業の財務・戦略的SWOT分析
    First Abu Dhabi Bank PJSC (FAB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Murata Manufacturing Co Ltd (6981):医療機器:M&Aディール及び事業提携情報
    Summary Murata Manufacturing Co., Ltd. (Murata) is an electronic component manufacturing company that designs, manufactures, and supplies a range of advanced electronic materials, components, and multi-functional, high-density modules. Its product portfolio includes capacitors, inductors, resistors, …
  • LifeLock Inc:企業のM&A・事業提携・投資動向
    LifeLock Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's LifeLock Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • University of South Florida-製薬・医療分野:企業M&A・提携分析
    Summary University of South Florida (USF) is an educational university that offers undergraduate, graduate, specialist and doctoral level degrees. The university offers degrees in various fields including accounting, advertising, Africana studies, American studies, anthropology, applied science, mar …
  • POET Technologies Inc (PTK):電力:M&Aディール及び事業提携情報
    Summary POET Technologies Inc (POET), a subsidiary of Pinetree Capital Ltd, is a technology company that develops integrated circuit platforms. The company provides products such as narrow linewidth laser, broadband light sources, data communications products and active and passive components, among …
  • Arthrex Inc-医療機器分野:企業M&A・提携分析
    Summary Arthrex Inc (Arthrex), formerly, Arthroscopy Excision Instruments Inc., is a medical device company which designs, and manufactures surgical products and solutions used for arthroscopic and minimally invasive orthopedic surgical procedures. The company offers shoulder, knee, elbow, hand and …
  • Epigenomics AG (ECX):医療機器:M&Aディール及び事業提携情報
    Summary Epigenomics AG (Epigenomics) is a molecular diagnostics company which develops and commercializes in-vitro diagnostic (IVD) tests for screening, early detection and diagnosis of cancer. Its lead product, Epi proColon is a blood-based test for rapid detection of colorectal cancer; and Epi pro …
  • Nutreco N.V.:企業の戦略・SWOT・財務情報
    Nutreco N.V. - Strategy, SWOT and Corporate Finance Report Summary Nutreco N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Southwire Company, LLC:企業の戦略・SWOT・財務情報
    Southwire Company, LLC - Strategy, SWOT and Corporate Finance Report Summary Southwire Company, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Berger Paints India Ltd (BERGEPAINT):企業の財務・戦略的SWOT分析
    Berger Paints India Ltd (BERGEPAINT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • ADM Tronics Unlimited Inc (ADMT):企業の財務・戦略的SWOT分析
    ADM Tronics Unlimited Inc (ADMT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Cypark Resources Berhad (CYPARK):企業の財務・戦略的SWOT分析
    Summary Cypark Resources Berhad (CRB) is a clean technology company that offers environmental engineering services. The company offers engineering and technology services on transforming dump sites to an economic and environmental boon. Its services include environmental remediation, integrated wast …
  • Velocys Plc (VLS):企業の財務・戦略的SWOT分析
    Velocys Plc (VLS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Empire Co Ltd:戦略・SWOT・企業財務分析
    Empire Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Empire Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Luitpold Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Luitpold Pharmaceuticals Inc (Luitpold Pharmaceuticals), a subsidiary of Daiichi Sankyo Co Ltd is a manufacturer and marketer of drugs and medical devices. The company provides products such as injectable parenteral medications that are used in pharmacy admixtures and nutrient solutions, cri …
  • SecureWorks Corp (SCWX):企業の財務・戦略的SWOT分析
    SecureWorks Corp (SCWX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Woodside Petroleum Ltd Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Woodside Petroleum Ltd Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Woodside Petroleum Ltd (Woodside) is an independent oil and gas company that explores, develops, produces and supplies energy. It explores and produces oil and gas from a portfolio of faciliti …
  • Consolidated Edison Company of New York, Inc.-エネルギー分野:企業M&A・提携分析
    Summary Consolidated Edison Company of New York, Inc. (CECONY), a subsidiary of Consolidated Edison, Inc. is an energy utility that generates, transmits and distributes electricity; supplies natural gas; and generates and supplies steam. The company provides electricity and related services in New Y …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆